BEGIN:VCALENDAR
VERSION:2.0
PRODID:PHP
BEGIN:VEVENT
DTSTART:20210715
SUMMARY:Epigenetic Therapeutic Targets
DESCRIPTION:<p>On July 15, 2021, Zenith presented&nbsp;at the Epigenetic Therapeutic Targets digital event</p>

<p>&quot;Clinical Development of The BET Bromodomain Inhibitor ZEN-3694 In Solid Tumors: Lessons Learned&quot;<br />
&bull; Design of epigenetic combinatorial therapies<br />
&bull; Clinical activity in breast and prostate cancer patients<br />
&bull; Mechanisms of action: similarities and differences between the prostate<br />
and breast cancer trials</p>
END:VEVENT
END:VCALENDAR